US poised to negotiate drug prices despite fierce pharma lobbying
Por um escritor misterioso
Descrição
Makers of blockbuster drugs including Eli Lilly, AbbVie and AstraZeneca face new curbs
The Inflation Reduction Act: Death By A Thousand Cuts For The Drug
Biden Can Reduce Prescription Drug Prices Without Congress, Warren
Biotechs lobby for their identity as drug pricing reforms set in
How PhRMA is trying to thwart Democrats' effort to lower drug prices
Who's Running Big Pharma's Last Stand Against Slightly Fairer Drug
U.S. move to negotiate drug prices a rare defeat for Big Pharma
Progressives Say 'It's Not Too Late' to Prevent Big Pharma From
Coronavirus: Big Pharma wages stealth war on drug price watchdog
US Drug Makers Push Profitable, But Unproven, Opioid Solution
Drug Pricing Lawsuits over the US Inflation Reduction Act Ramp Up
NEW REPORT: “Why Medicare Needs the Power to Negotiate for Lower
U.S. move to negotiate drug prices a rare defeat for Big Pharma
What's next for drug pricing in 2023
A bitter pill: how big pharma lobbies to keep prescription drug
Why Medicare Is Right To Negotiate Drug Prices
de
por adulto (o preço varia de acordo com o tamanho do grupo)